EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

ADAR1 and ZBP1 in innate immunity, cell death, and disease

Rajendra Karki, Thirumala-Devi Kanneganti

Trends in Immunology · 2023-03 · 44 (3) · 201-216

DOI: 10.1016/j.it.2023.01.001 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Immunology, 2023-03. Verfasst von Rajendra Karki und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA. Hauptthemen laut MEDLINE: Immunity, Innate, Nucleic Acids. Die Arbeit wurde bisher 121-mal zitiert (Crossref) und nennt 110 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ADAR1 and ZBP1 are the only two mammalian proteins that contain Zα domains, which are thought to bind to nucleic acids in the Z-conformation. These two molecules are crucial in regulating diverse biological processes. While ADAR1-mediated RNA editing supports host survival and development, ZBP1-mediated immune responses provide host defense against infection and disease. Recent studies have expanded our understanding of the functions of ADAR1 and ZBP1 beyond their classical roles and established their fundamental regulation of innate immune responses, including NLRP3 inflammasome activation, inflammation, and cell death. Their roles in these processes have physiological impacts across development, infectious and inflammatory diseases, and cancer. In this review, we discuss the functions of ADAR1 and ZBP1 in regulating innate immune responses in development and disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunity, InnateNucleic AcidsAnimalsHumansCell DeathInflammationMammalsAdenosine DeaminaseRNA-Binding Proteins

Stichwörter der Autor:innen

ADAR1NLRP3PANoptosisPANoptosomeRIPK1RIPK3ZBP1Zα domainapoptosiscancercaspasecell deathdevelopmenthomeostasisinfection

Substanzen

Nucleic AcidsADAR protein, humanAdenosine DeaminaseRNA-Binding ProteinsZBP1 protein, human

Autor:innen und Institutionen

  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA.
  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, 38105, USA. Electronic address: Thirumala-Devi.Kanneganti@StJude.org.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NIAMS NIH HHS
  • Pfizer
  • American Lebanese Syrian Associated Charities
  • National Institutes of Health

Zitieren

APA

Karki, R., & Kanneganti, T. D. (2023). ADAR1 and ZBP1 in innate immunity, cell death, and disease. Trends in Immunology, 44(3), 201-216. https://doi.org/10.1016/j.it.2023.01.001

Vancouver

Karki R, Kanneganti TD. ADAR1 and ZBP1 in innate immunity, cell death, and disease. Trends in Immunology. 2023;44(3):201-216. doi:10.1016/j.it.2023.01.001

BibTeX
@article{Karki2023,
  author = {Karki, Rajendra and Kanneganti, Thirumala-Devi},
  title = {ADAR1 and ZBP1 in innate immunity, cell death, and disease},
  journal = {Trends in Immunology},
  year = {2023},
  volume = {44},
  number = {3},
  pages = {201--216},
  doi = {10.1016/j.it.2023.01.001}
}
Kostenlos starten →